Of the functional tumors, 6 (26%) were gastrinomas, 9 (39%) were insulinomas, 3 (13%) were glucagonomas, and 4 (17%) were vasoactive intestinal peptide tumors. The gene discussed is VIP; the disease is gastrin-producing neuroendocrine tumor.